Improved interpretation and clinical validation of substitutions in HIV-1 protease predicting the virological response to darunavir/ritonavir

被引：0
|
作者：
De Luca, A. [1 ]
Di Giambenedetto, S. [1 ]
Marando, F. [2 ]
Maserati, R. [3 ]
Gianotti, N. [4 ]
Narciso, P. [5 ]
Antinori, A. [5 ]
Di Perri, G. [6 ]
Baldanti, F. [3 ]
Zazzi, M. [7 ]
Perno, C. F. [2 ]
Santoro, M. M. [2 ]
机构：
[1] Catholic Univ, Rome, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
[3] Policlin San Matteo IRCCS, Pavia, Italy
[4] Hosp San Raffaele, I-20132 Milan, Italy
[5] IRCCS, Natl Inst Infect Dis L Spallanzani, Rome, Italy
[6] Univ Turin, Turin, Italy
[7] Univ Siena, I-53100 Siena, Italy
来源：
ANTIVIRAL THERAPY | 2008年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：A104 / A104
页数：1
相关论文
共 50 条
  • [21] Factors Associated With Virological Failure in HIV-1-Infected Patients Receiving Darunavir/Ritonavir Monotherapy
    Lambert-Niclot, Sidonie
    Flandre, Philippe
    Valantin, Marc-Antoine
    Peytavin, Gilles
    Duvivier, Claudine
    Haim-Boukobza, Stephanie
    Algarte-Genin, Michele
    Yazdanpanah, Yazdan
    Girard, Pierre-Marie
    Katlama, Christine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (08): : 1211 - 1216
  • [22] Darunavir (TMC114): a new HIV-1 protease inhibitor
    Molina, Jean-Michel
    Hill, Andrew
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (12) : 1951 - 1964
  • [23] Pharmacokinetic Interactions Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Ritonavir-Boosted HIV-1 Protease Inhibitors Atazanavir, Darunavir, and Lopinavir
    Hulskotte, Ellen G. J.
    Feng, Hwa-Ping
    Xuan, Fengjuan
    van Zutven, Marge G. J. A.
    Treitel, Michelle A.
    Hughes, Eric A.
    O'Mara, Edward
    Youngberg, Stephen P.
    Wagner, John A.
    Butterton, Joan R.
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (05) : 718 - 726
  • [24] Impact of baseline protease mutations on virological response to darunavir-ritonavir-containing therapy in protease inhibitor-experienced patients (PREDIZISTA Study)
    Pellegrin, I.
    Wittkop, L.
    Breilh, D.
    Merel, P.
    Winters, B.
    Bonarck, M.
    Neau, D.
    Bollens, D.
    Pellegrin, J. L.
    Girard, P. M.
    Fleury, H. J. A.
    Saux, M. C.
    Thiebaut, R.
    Morand-Joubert, L.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S22 - S22
  • [25] Impact of baseline protease mutations on virological response to darunavir-ritonavir-containing therapy in protease inhibitor-experienced patients (PREDIZISTA Study)
    Pellegrin, I.
    Wittkop, L.
    Breilh, D.
    Merel, P.
    Winters, B.
    Bonarek, M.
    Neau, D.
    Bollens, D.
    Pellegrin, J. L.
    Girard, P. M.
    Fleury, H. J. A.
    Saux, M. C.
    Thiebaut, R.
    Morand-Joubert, L.
    ANTIVIRAL THERAPY, 2007, 12 : S22 - S22
  • [26] Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection
    Calza, L.
    Colangeli, V.
    Magistrelli, E.
    Bussini, L.
    Conti, M.
    Ramazzotti, E.
    Mancini, R.
    Viale, P.
    HIV MEDICINE, 2017, 18 (07) : 474 - 481
  • [27] Predicting substrate specificity in HIV-1 protease
    Ozer, N
    Schiffer, CA
    Haliloglu, T
    PROTEIN SCIENCE, 2004, 13 : 193 - 194
  • [28] External validation of atazanavir/ritonavir genotypic score in HIV-1 protease inhibitor-experienced patients
    Marcelin, G
    Chazallon, C
    Gerard, L
    Saïdi, Y
    Aboulker, JP
    Girard, PM
    Calvez, V
    Piketty, C
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 42 (01) : 127 - 128
  • [29] Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patients
    Malet, Isabelle
    Roquebert, Benedicte
    Dalban, Cecile
    Wirden, Marc
    Amellal, Bahia
    Agher, Rachid
    Simon, Anne
    Katlama, Christine
    Costagliola, Dominique
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    JOURNAL OF INFECTION, 2007, 54 (04) : 367 - 374
  • [30] Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy
    Ucciferri, Claudio
    Falasca, Katia
    Vignale, Francesca
    Di Nicola, Marta
    Pizzigallo, Eligio
    Vecchiet, Jacopo
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (05) : 755 - 759
12345